Yamashita Health Care Holdings,Inc. (TYO:9265)
3,885.00
+345.00 (9.75%)
Apr 3, 2026, 3:30 PM JST
TYO:9265 Revenue
Yamashita Health Care Holdings,Inc. had revenue of 16.24B JPY in the quarter ending February 28, 2026, with 0.33% growth. This brings the company's revenue in the last twelve months to 63.82B, up 0.14% year-over-year. In the fiscal year ending May 31, 2025, Yamashita Health Care Holdings,Inc. had annual revenue of 64.49B with 4.76% growth.
Revenue (ttm)
63.82B
Revenue Growth
+0.14%
P/S Ratio
0.15
Revenue / Employee
104.11M
Employees
613
Market Cap
9.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 64.49B | 2.93B | 4.76% |
| May 31, 2024 | 61.56B | 3.36B | 5.77% |
| May 31, 2023 | 58.20B | 3.05B | 5.53% |
| May 31, 2022 | 55.15B | -14.99B | -21.37% |
| May 31, 2021 | 70.13B | 5.47B | 8.46% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Otsuka Holdings | 2.47T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| Morishita Jintan | 12.87B |
| Koken | 11.86B |
| Softmax | 6.93B |
| OncoTherapy Science | 784.00M |